To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Division Vote (Commons)
15 Apr 2026 - Deferred Division - View Vote Context
Siobhain McDonagh (Lab) voted Aye - in line with the party majority and in line with the House
One of 290 Labour Aye votes vs 0 Labour No votes
Vote Tally: Ayes - 299 Noes - 169
Division Vote (Commons)
15 Apr 2026 - Deferred Division - View Vote Context
Siobhain McDonagh (Lab) voted Aye - in line with the party majority and in line with the House
One of 237 Labour Aye votes vs 12 Labour No votes
Vote Tally: Ayes - 247 Noes - 21
Division Vote (Commons)
15 Apr 2026 - Deferred Division - View Vote Context
Siobhain McDonagh (Lab) voted Aye - in line with the party majority and in line with the House
One of 274 Labour Aye votes vs 0 Labour No votes
Vote Tally: Ayes - 278 Noes - 73
Division Vote (Commons)
15 Apr 2026 - Deferred Division - View Vote Context
Siobhain McDonagh (Lab) voted Aye - in line with the party majority and in line with the House
One of 276 Labour Aye votes vs 1 Labour No votes
Vote Tally: Ayes - 281 Noes - 70
Division Vote (Commons)
15 Apr 2026 - Deferred Division - View Vote Context
Siobhain McDonagh (Lab) voted Aye - in line with the party majority and in line with the House
One of 241 Labour Aye votes vs 1 Labour No votes
Vote Tally: Ayes - 301 Noes - 157
Division Vote (Commons)
15 Apr 2026 - Deferred Division - View Vote Context
Siobhain McDonagh (Lab) voted Aye - in line with the party majority and in line with the House
One of 284 Labour Aye votes vs 0 Labour No votes
Vote Tally: Ayes - 300 Noes - 101
Division Vote (Commons)
15 Apr 2026 - Deferred Division - View Vote Context
Siobhain McDonagh (Lab) voted Aye - in line with the party majority and in line with the House
One of 271 Labour Aye votes vs 0 Labour No votes
Vote Tally: Ayes - 277 Noes - 158
Division Vote (Commons)
15 Apr 2026 - Deferred Division - View Vote Context
Siobhain McDonagh (Lab) voted Aye - in line with the party majority and in line with the House
One of 285 Labour Aye votes vs 0 Labour No votes
Vote Tally: Ayes - 291 Noes - 174
Speech in Commons Chamber - Tue 14 Apr 2026
Oral Answers to Questions

"At 2 pm today, many Members of this House will be attending the funeral of our dear friend Phil Woolas, the Member for Oldham East and Saddleworth from 1997 to 2010, who passed away from a glioblastoma brain tumour on 14 March. I am sure that everybody would wish to …..."
Siobhain McDonagh - View Speech

View all Siobhain McDonagh (Lab - Mitcham and Morden) contributions to the debate on: Oral Answers to Questions
Written Question
Brain: Tumours
Tuesday 14th April 2026

Asked by: Siobhain McDonagh (Labour - Mitcham and Morden)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the performance of the National Institute for Health and Care Research Brain Tumour Research Consortium on improving the treatment of glioblastoma brain tumours.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

The Department invests over £1.7 billion per year in research through the National Institute for Health and Care Research (NIHR).

We are committed to furthering our investment in brain cancer research and have already taken steps to stimulate scientific progress and build scientific capacity to do research on brain cancer.

In January 2026, the NIHR announced increased investment of over £25 million in the NIHR Brain Tumour Research Consortium. The world-leading consortium aims to transform outcomes for adults and children and their families who are living with brain tumours - ultimately reducing lives lost to cancer.

Activity is still in the early stages of delivery however, we will ensure that the impact of these investments reaches patients as quickly as possible.

Information on all awards will be made available on NIHR Funding and Awards pages in due course. NIHR is working to ensure that new investments can get up and running as soon as possible.

In addition, the NIHR continues to strongly encourage brain cancer research applications through its regular funding opportunities.